Amin Mirhadi, MD, is an assistant professor at Cedars-Sinai Medical Center in Los Angeles, California, where he is the ...

The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...

New reports reveal rising insurance costs, senior drug savings, and cancer care inequities, showing how policy and ...

Nicholas Richardson, DO, at Precision for Medicine, breaks down minimal residual disease and MRD negativity as FDA end points ...

Ibrutinib was a breakthrough when it was first approved to treat R/R MCL in 2013, and a year later for patients with at least 1 prior treatment for chronic lymphocytic leukemia. However, its ...

A new study links telomere length genetics to IPF risk, showing how rare variants and polygenic scores may guide future screening and precision care.

In this interview with the study’s lead author, Sarah M. Lima, PhD, MPH, an epidemiologist and postdoctoral fellow in cancer populations at the Georgetown Lombardi Comprehensive Cancer Center, she ...

David Zhang, MD, is a pulmonary disease medicine specialist at Columbia University Irving Medical Center. A new study links telomere length genetics to IPF risk, showing how rare variants and ...

However, quitting smoking lowers the risks of at least 12 different types of cancer, including cancers of the lung, liver, and esophagus. The longer an individual remains smoke free, the more their ...

“Decision-making is a critical component of health care delivery, but the number of therapies available can be overwhelming to patients, preventing them from making fully informed care decisions,” the ...

Study finds breast cancer survival gaps tied to historical redlining narrowed over time, though newer therapies may be widening disparities again.

Translating academic practices into a community oncology setting requires meaningful adaptations to successfully integrate practices like adoptive cell therapy, CAR-T therapies, or TCR-T therapies, ...